T1	Participants 71 99	anemic patients with cancer.
T2	Participants 216 254	patients with cancer-associated anemia
T3	Participants 277 331	Eligible patients were randomly assigned at enrollment
T4	Participants 556 603	Three hundred sixty-five patients were enrolled
